Opportunity Information: Apply for CDC RFA GH15 1514
Apply for CDC RFA GH15 1514
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening the Capacity of the Republican AIDS Center to Implement HIV Program in the Republic of Tajikistan under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Sep 11, 2014 and posted on Sep 11, 2014.
- Applicants must submit their applications by Nov 8, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The Republican AIDS Center is the only department within the Ministry of Health of the Republic of Tajikistan that has the mandate to implement and/or coordinate HIV/AIDS activities as outlined below. The Republican AIDS Center (RAC) will work in collaboration with the HHS/CDC CAR office to improve the breadth, scale, and quality of HIV and co infection services available throughout the country. In addition to program implementation, RAC will engage in building the capacity development of organization responsible for HIV and co infection services in the country. The RAC will strengthen capacity and expand activities in the areas of (1) HIV and co infection prevention (2) HIV and co infection care, support, and treatment and (3) capacity and infrastructure development. Awards will focus on one or more of the following activities key populations (KP) and vulnerable population interventions for HIV/AIDS and other co infections, including outreach services, needle syringe exchange program, counseling and testing and referral linkages infection prevention and control practices of healthcare facilities basic care and support for HIV/AIDS and co infections treatment services for HIV/AIDS and co infections strengthening strategic information, including data collection and analysis, surveillance, health information management system, and monitoring and evaluation and capacity building and development of HIV/AIDS and other co infections staff. This funding opportunity announcement (FOA) is designed to begin on April 1, 2015 and replace FOA PS10 1016505 which ends March 31, 2015. The similar request was made for the Republican AIDS Center on January 20, 2010 while applying for FOA PS10 1016505. The request was approved.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Strengthening the Capacity of the Republican AIDS Center to Implement HIV Program in the Republic of Tajikistan under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a CDC cooperative agreement designed to strengthen Tajikistan's national HIV response through the Republican AIDS Center (RAC) within the Ministry of Health. The overall aim is to expand the reach and quality of HIV prevention and medical services, particularly for key populations most affected by the epidemic, while also improving how HIV services are integrated into routine healthcare and how the country tracks and understands HIV trends. The FOA was posted on September 11, 2014, closed on November 8, 2014, and was intended to start on April 1, 2015, replacing an earlier CDC funding mechanism (FOA PS10-1016505) that ended March 31, 2015.
The programmatic focus centers on increasing coverage of comprehensive, high-quality HIV prevention and improving access to medical services for key populations. In the context of Tajikistan, the FOA specifically calls out people who inject drugs and sex workers, and also highlights the importance of understanding the epidemic among men who have sex with men. Activities contemplated under this focus include interventions such as community outreach, needle and syringe exchange programming, counseling and HIV testing services, and stronger referral and linkage systems so that individuals reached through prevention programs can move quickly into confirmatory testing, clinical care, and treatment when needed. The intent is not only to deliver more services, but to ensure they are consistent, evidence-informed, and connected to the rest of the health system rather than operating in isolation.
A second major emphasis is service integration. The FOA supports integrating HIV testing, care, and treatment into primary healthcare as well as into tuberculosis, sexually transmitted infection, and narcology services. This reflects a practical goal: making HIV services easier to access in the places where people already seek care, including settings that key populations and people living with HIV may use more frequently. Integration is meant to improve availability and continuity of services, reduce missed opportunities for diagnosis and treatment, and strengthen co-infection management (notably TB/HIV). Alongside integration, the FOA also mentions infection prevention and control practices in healthcare facilities, signaling attention to clinical quality and patient safety as services expand.
A third core element is strategic information and epidemic understanding. The FOA explicitly supports ongoing efforts to better understand HIV trends among key populations and to gather improved size estimates of these populations. This type of work typically underpins smarter program planning, targeting, and resource allocation, since decision-makers need credible data on where transmission is occurring, which groups are most affected, and whether interventions are reaching the intended audiences. The announcement points to strengthening data collection and analysis, surveillance, health information management systems, and monitoring and evaluation. In practice, this means building the systems and workforce capacity needed to generate usable data and translate it into decisions that improve program performance.
Eligibility is narrowly defined. The Republican AIDS Center is identified as the only entity within the Tajik Ministry of Health with the mandate to implement and coordinate HIV/AIDS activities for this scope of work, and the FOA indicates that RAC will work in collaboration with the HHS/CDC Central Asia Region office. The cooperative agreement structure also implies substantial involvement by CDC beyond simple pass-through funding, often including joint planning, technical assistance, and performance monitoring. The FOA frames RAC not only as an implementer but also as a national capacity builder, responsible for strengthening the organizations and staff delivering HIV and co-infection services across the country.
From a funding standpoint, the opportunity is listed under CFDA 93.067 (Global AIDS), with an expected single award. The award ceiling is stated as $400,000, with no cost-sharing or matching requirement. The estimated total funding field is shown as zero in the source data, which can happen in archived listings even when an award ceiling is provided, so the ceiling is the best indicator of the potential maximum award amount in the announcement text provided.
In summary, the FOA is essentially a capacity-strengthening and service-expansion package for Tajikistan's national HIV program led by the Republican AIDS Center, with three intertwined goals: expand and improve prevention and service access for key populations (especially PWID and sex workers), integrate HIV services into primary care and related clinical services like TB/STI/narcology to improve availability and continuity for people living with HIV, and strengthen strategic information systems so the country can track the epidemic more accurately and make better, evidence-based program decisions. For applicants or stakeholders needing the archived full announcement but encountering access issues, the CDC Procurement and Grants Office Technical Information Management Section is listed as the contact point (phone: 770-488-2700).
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled "Strengthening the Capacity of the Republican AIDS Center to Implement HIV Program in the Republic of Tajikistan under the President's Emergency Plan for AIDS Relief (PEPFAR)."
Which U.S. agency is offering this award?
This is a CDC (Centers for Disease Control and Prevention) cooperative agreement.
What is the overall purpose of the cooperative agreement?
The purpose is to strengthen Tajikistan's national HIV response through the Republican AIDS Center (RAC) within the Ministry of Health by expanding the reach and quality of HIV prevention and medical services, improving integration of HIV services into routine healthcare, and strengthening how the country tracks and understands HIV trends.
How does this opportunity relate to PEPFAR?
The program is explicitly described as being under the President's Emergency Plan for AIDS Relief (PEPFAR) and supports HIV prevention, care, treatment, and data systems strengthening aligned with that context.
Who is the primary implementing partner in Tajikistan?
The Republican AIDS Center (RAC) within the Tajik Ministry of Health is the named entity for implementing and coordinating the HIV/AIDS activities described in this scope of work.
Who is eligible to apply?
Eligibility is narrowly defined in the provided description: the Republican AIDS Center is identified as the only entity within the Tajik Ministry of Health with the mandate to implement and coordinate HIV/AIDS activities for this scope of work.
How many awards were expected?
The opportunity indicates an expected single award.
What is the funding amount (maximum award)?
The award ceiling is stated as $400,000, which is the best indicator of the maximum potential award amount based on the information provided.
Is cost sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement.
What CFDA program does this fall under?
The opportunity is listed under CFDA 93.067 (Global AIDS).
What type of award mechanism is this?
It is a cooperative agreement, which implies substantial involvement by CDC beyond pass-through funding, such as joint planning, technical assistance, and performance monitoring.
What are the main program priorities or focus areas?
Three core elements are emphasized: (1) expanding and improving HIV prevention and access to medical services for key populations, (2) integrating HIV testing, care, and treatment into primary healthcare and related services, and (3) strengthening strategic information systems to better understand HIV trends and guide decision-making.
Which key populations are specifically highlighted?
The description specifically calls out people who inject drugs and sex workers, and it highlights the importance of better understanding the epidemic among men who have sex with men.
What kinds of HIV prevention activities are contemplated?
Examples listed include community outreach, needle and syringe exchange programming, counseling and HIV testing services, and stronger referral and linkage systems to move people efficiently into confirmatory testing, clinical care, and treatment when needed.
Does the opportunity emphasize service quality as well as coverage?
Yes. It stresses comprehensive, high-quality services that are consistent, evidence-informed, and connected to the broader health system rather than operating in isolation.
What does "service integration" mean in this opportunity?
Integration refers to incorporating HIV testing, care, and treatment into primary healthcare and into tuberculosis (TB), sexually transmitted infection (STI), and narcology services to improve access, continuity, and co-infection management.
Why integrate HIV services into TB, STI, and narcology services?
The stated rationale is practical: making HIV services available in places people already seek care, reducing missed opportunities for diagnosis and treatment, improving continuity of services, and strengthening management of co-infections (notably TB/HIV).
Are infection prevention and control measures part of the scope?
Yes. The description mentions infection prevention and control practices in healthcare facilities, signaling attention to clinical quality and patient safety as services expand.
What does the opportunity say about strategic information and surveillance?
It supports ongoing efforts to better understand HIV trends among key populations, improve size estimates of those populations, strengthen data collection and analysis, bolster surveillance and health information management systems, and enhance monitoring and evaluation so data can be used to improve program performance.
Why are size estimates of key populations mentioned?
The provided description explains that credible size estimates and trend data support smarter program planning, targeting, and resource allocation by showing where transmission is occurring, which groups are most affected, and whether interventions are reaching intended audiences.
What collaboration is expected with CDC?
RAC is expected to work in collaboration with the HHS/CDC Central Asia Region office, consistent with a cooperative agreement model involving CDC engagement in planning, technical assistance, and monitoring.
Is this a new funding mechanism or a continuation/replacement?
It is described as replacing an earlier CDC funding mechanism (FOA PS10-1016505) that ended on March 31, 2015.
When was the FOA posted and when did it close?
The FOA was posted on September 11, 2014, and closed on November 8, 2014.
What was the intended project start date?
The intended start date was April 1, 2015.
Who should be contacted for issues accessing the archived announcement?
The CDC Procurement and Grants Office Technical Information Management Section is listed as the contact point. Phone: 770-488-2700.
Why might the "estimated total funding" appear as zero in some listings?
The provided information notes that archived listings can show an estimated total funding field as zero even when an award ceiling is provided; in that situation, the ceiling is presented as the best indicator of the potential maximum award amount.
Browse more opportunities from the same category: Health
Next opportunity: Supporting HIV and Tuberculosis Response in the Kingdom of Lesotho through District based Comprehensive Prevention, Care and Treatment Programs and Health Systems Strengthening under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Improving PMTCT and Quality of HIV Treatment and STI Surveillance and Increasing Capacity to Address Needs for Key Populations in the Dominican Republic Ministry of Health under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1514
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1514) also looked into and applied for these:
| Funding Opportunity |
|---|
| Supporting HIV and Tuberculosis Response in the Kingdom of Lesotho through District based Comprehensive Prevention, Care and Treatment Programs and Health Systems Strengthening under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1548 Funding Number: CDC RFA GH15 1548 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Technical Assistance for Laboratory Systems Strengthening in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1560 Funding Number: CDC RFA GH15 1560 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Request to Access Parkinsons Disease Related Biospecimens (X01) Apply for PAR 14 340 Funding Number: PAR 14 340 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epigenetic Analyses of Aging as a Risk Factor for Multiple Chronic Conditions (U34) Apply for RFA AG 15 004 Funding Number: RFA AG 15 004 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| NIAID Career Transition Award (K22) Apply for PAR 14 341 Funding Number: PAR 14 341 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical and Translational Science Award (U54) Apply for RFA TR 14 009 Funding Number: RFA TR 14 009 Agency: National Institutes of Health Category: Health Funding Amount: $10,000,000 |
| Immunization Information Systems (IIS) Apply for CDC RFA IP13 130203CONT15 Funding Number: CDC RFA IP13 130203CONT15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Capacity Building of Provincial Health Directorates (DPSs) in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1561 Funding Number: CDC RFA GH15 1561 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Strengthening the Delivery, Coordination, and Monitoring of HIV Services in Malawi through Faith based Institutions under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1550 Funding Number: CDC RFA GH15 1550 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,100,000 |
| South African University based Technical Assistance Aimed at Improving the quality of HIV/AIDS and related services in the Republic of South Africa under the United States Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1574 Funding Number: CDC RFA GH15 1574 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Improving Medical Education in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1552 Funding Number: CDC RFA GH15 1552 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Support of Civil Registration and Vital Statistics in Malawi through the National Registration Bureau under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1554 Funding Number: CDC RFA GH15 1554 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Building Effective Health Information Systems under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1535 Funding Number: CDC RFA GH15 1535 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,600,000 |
| Technical Assistance and Support for the Development and Implementation of Key Aspects of HIV/AIDS Care and Support Services in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1578 Funding Number: CDC RFA GH15 1578 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,500,000 |
| Peer to Peer Capacity Building in the Public Sector to Support Management, Leadership, and Sustainability of HIV Programs in PEPFAR Countries under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1532 Funding Number: CDC RFA GH15 1532 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM PHACTS) under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1615 Funding Number: CDC RFA GH15 1615 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Analyses of Datasets on Older Populations with High Prevalence of Mobility Disability to Develop Clinically Meaningful Diagnostic Cut Points for Low Muscle Mass and/or Low Muscle Strength (U01) Apply for RFA AG 15 013 Funding Number: RFA AG 15 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 15 012 Funding Number: HRSA 15 012 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 15 013 Funding Number: HRSA 15 013 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIDCR Behavioral or Social Intervention Clinical Trial Planning Grant (R34) Apply for PAR 14 342 Funding Number: PAR 14 342 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1514", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.